Klaus Gebhardt

1.2k total citations
25 papers, 947 citations indexed

About

Klaus Gebhardt is a scholar working on Pharmacology, Molecular Biology and Spectroscopy. According to data from OpenAlex, Klaus Gebhardt has authored 25 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 10 papers in Molecular Biology and 6 papers in Spectroscopy. Recurrent topics in Klaus Gebhardt's work include Microbial Natural Products and Biosynthesis (11 papers), Analytical Chemistry and Chromatography (4 papers) and Mass Spectrometry Techniques and Applications (4 papers). Klaus Gebhardt is often cited by papers focused on Microbial Natural Products and Biosynthesis (11 papers), Analytical Chemistry and Chromatography (4 papers) and Mass Spectrometry Techniques and Applications (4 papers). Klaus Gebhardt collaborates with scholars based in Germany, Switzerland and United States. Klaus Gebhardt's co-authors include Hans‐Peter Fiedler, Guido Schmiemann, Eva Hummers, Judith Schimana, Axel Zeeck, Philipp Krastel, Dietmar G. Schmid, Alexandra Höltzel, Joachim Rheinheimer and Rüdiger Pukall and has published in prestigious journals such as Cancer Research, Antimicrobial Agents and Chemotherapy and Journal of Chromatography A.

In The Last Decade

Klaus Gebhardt

25 papers receiving 903 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Klaus Gebhardt Germany	13	399	316	252	142	98	25	947
Shōgo Kuwahara Japan	22	429 1.1×	643 2.0×	447 1.8×	173 1.2×	56 0.6×	82	1.7k
Sachiko Gotô Japan	20	411 1.0×	346 1.1×	121 0.5×	141 1.0×	50 0.5×	92	1.1k
YASUHIRO MINE Japan	22	372 0.9×	466 1.5×	125 0.5×	185 1.3×	33 0.3×	60	1.2k
Paul Actor United States	17	277 0.7×	320 1.0×	167 0.7×	191 1.3×	33 0.3×	72	988
Karen Ingraham United States	17	823 2.1×	227 0.7×	340 1.3×	109 0.8×	45 0.5×	22	1.4k
M Berti Italy	17	493 1.2×	520 1.6×	153 0.6×	243 1.7×	85 0.9×	43	1.1k
James J. Burchall United States	20	849 2.1×	151 0.5×	344 1.4×	136 1.0×	47 0.5×	32	1.6k
R. T. TESTA United States	20	544 1.4×	663 2.1×	166 0.7×	209 1.5×	83 0.8×	34	1.4k
Jarrod B. King United States	25	483 1.2×	485 1.5×	75 0.3×	211 1.5×	154 1.6×	44	1.5k
S. Mochales United States	9	486 1.2×	563 1.8×	203 0.8×	351 2.5×	70 0.7×	10	1.3k

Countries citing papers authored by Klaus Gebhardt

Since Specialization

Citations

This map shows the geographic impact of Klaus Gebhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Gebhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Gebhardt more than expected).

Fields of papers citing papers by Klaus Gebhardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Gebhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Gebhardt. The network helps show where Klaus Gebhardt may publish in the future.

Co-authorship network of co-authors of Klaus Gebhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Gebhardt. A scholar is included among the top collaborators of Klaus Gebhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Gebhardt. Klaus Gebhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gebhardt, Klaus, et al.. (2013). Experiments for a systematic comparison between stable-isotope-(deuterium) labeling and radio-(14C) labeling for the elucidation of the in vitro metabolic pattern of pharmaceutical drugs. Journal of Pharmaceutical and Biomedical Analysis. 85. 138–144. 5 indexed citations

Page, Malcolm G. P., et al.. (2011). In Vitro and In Vivo Properties of BAL30376, a β-Lactam and Dual β-Lactamase Inhibitor Combination with Enhanced Activity against Gram-Negative Bacilli That Express Multiple β-Lactamases. Antimicrobial Agents and Chemotherapy. 55(4). 1510–1519. 38 indexed citations

Gebhardt, Klaus, et al.. (2010). Phenalinolactones A–D, terpenoglycoside antibiotics from Streptomyces sp. Tü 6071. The Journal of Antibiotics. 64(3). 229–232. 17 indexed citations

Schmiemann, Guido, et al.. (2010). The Diagnosis of Urinary Tract Infection. Deutsches Ärzteblatt international. 107(21). 361–7. 323 indexed citations

Wind, Mathias, Klaus Gebhardt, Jochen Spickermann, et al.. (2009). Investigation of the species-dependent in vitro metabolism of BAL30630 by stable isotope labeling and isotope exchange experiments analyzed by capillary liquid chromatography coupled to mass spectrometry. Journal of Chromatography A. 1216(18). 3946–3953. 5 indexed citations

Wind, Mathias, Klaus Gebhardt, Jochen Spickermann, et al.. (2007). Elucidation of the in vitro metabolic profile of stable isotope labeled BAL19403 by accurate mass capillary liquid chromatography/quadrupole time‐of‐flight mass spectrometry and isotope exchange. Rapid Communications in Mass Spectrometry. 21(7). 1093–1099. 11 indexed citations

Wind, Mathias, Jochen Spickermann, Michael Schleimer, et al.. (2006). Investigation of low‐abundant in vitro metabolites of stable isotope‐labelled BAL4815 by accurate mass capillary‐LC‐ESI‐qTof‐MS and MS/MS. Journal of Mass Spectrometry. 41(7). 903–910. 4 indexed citations

Vater, Joachim, et al.. (2005). Whole cell matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry and in situ structure analysis of streptocidins, a family of tyrocidine‐like cyclic peptides. Rapid Communications in Mass Spectrometry. 19(20). 2935–2942. 6 indexed citations

Höltzel, Alexandra, Dietmar G. Schmid, Graeme Nicholson, et al.. (2004). Aspochalamins A-D and Aspochalasin Z Produced by the Endosymbiotic Fungus Aspergillus niveus LU 9575: II. Structure Elucidation. The Journal of Antibiotics. 57(11). 715–720. 15 indexed citations

10.

Gebhardt, Klaus, Judith Schimana, Alexandra Höltzel, et al.. (2004). Aspochalamins A-D and Aspochalasin Z Produced by the Endosymbiotic Fungus Aspergillus niveus LU 9575: I. Taxonomy, Fermentation, Isolation and Biological Activities. The Journal of Antibiotics. 57(11). 707–714. 20 indexed citations

11.

Gebhardt, Klaus, Judith Schimana, Philipp Krastel, et al.. (2003). Endophenazines A—D, New Phenazine Antibiotics from the Arthropod Associated Endosymbiont Streptomyces anulatus. Part 1. Taxonomy, Fermentation, Isolation and Biological Activities.. ChemInform. 34(9). 10 indexed citations

12.

Krastel, Philipp, Axel Zeeck, Klaus Gebhardt, Hans‐Peter Fiedler, & Joachim Rheinheimer. (2002). Biosynthetic Capacities of Actinomysetes. No.27. Endophenazines A-D, New Phenazine Antibiotics from the Athropod Associated Endosymbiont Streptomyces anulatus. II. Structure Elucidation.. The Journal of Antibiotics. 55(9). 801–806. 39 indexed citations

13.

Gebhardt, Klaus, Judith Schimana, Hans‐Peter Fiedler, et al.. (2002). Screening for biologically active metabolites with endosymbiotic bacilli isolated from arthropods. FEMS Microbiology Letters. 217(2). 199–205. 58 indexed citations

14.

Schimana, Judith, Klaus Gebhardt, Alexandra Höltzel, et al.. (2002). Arylomycins A and B, New Biaryl-bridged Lipopeptide Antibiotics Produced by Streptomyces sp. Tue 6075. I. Taxonomy, Fermentation, Isolation and Biological Activities.. The Journal of Antibiotics. 55(6). 565–570. 123 indexed citations

15.

Höltzel, Alexandra, Dietmar G. Schmid, Graeme Nicholson, et al.. (2002). Arylomycins A and B, New Biaryl-bridged Lipopeptide Antibiotics Produced by Streptomyces sp. Tue 6075. II. Structure Elucidation.. The Journal of Antibiotics. 55(6). 571–577. 74 indexed citations

16.

Gebhardt, Klaus, Judith Schimana, Philipp Krastel, et al.. (2002). Biosynthetic Capacities of Actinomysetes. No.26. Endophenazines A-D, New Phenazine Antibiotics from the Arthropod Associated Endosymbiont Streptomyces anulatus. I. Taxonomy, Fermentation, Isolation and Biological Activities.. The Journal of Antibiotics. 55(9). 794–800. 63 indexed citations

17.

Höltzel, Alexandra, Ralph W. Jack, Graeme Nicholson, et al.. (2001). Streptocidins A-D, Novel Cyclic Decapeptide Antibiotics Produced by Streptomyces sp. Tue 6071. II. Structure Elucidation.. The Journal of Antibiotics. 54(5). 434–440. 18 indexed citations

18.

Fiedler, Hans‐Peter, et al.. (2001). Enterobactin: the characteristic catecholate siderophore of Enterobacteriaceae is produced byStreptomycesspecies. FEMS Microbiology Letters. 196(2). 147–151. 66 indexed citations

19.

Gebhardt, Klaus, Rüdiger Pukall, & Hans‐Peter Fiedler. (2001). Streptocidins A-D, Novel Cyclic Decapeptide Antibiotics Produced by Streptomyces sp. Tue 6071. I. Taxonomy, Fermentation, Isolation and Biological Activities.. The Journal of Antibiotics. 54(5). 428–433. 18 indexed citations

20.

Hoetzel, Alexander, et al.. (2001). ChemInform Abstract: Streptocidins A—D, Novel Cyclic Decapeptide Antibiotics Produced by Streptomyces sp. Tue 6071. Part 2. Structure Elucidation.. ChemInform. 32(43). 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact